Alpha Tau Medical (DRTS) furnishes Q3 2025 results and update via 6-K
Rhea-AI Filing Summary
Alpha Tau Medical Ltd. filed a Form 6-K to furnish a press release titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update,” dated November 20, 2025. The report incorporates this press release by reference into the company’s existing Form F-3 and Form S-8 registration statements.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Alpha Tau Medical Ltd. (DRTS) file in this Form 6-K?
Alpha Tau Medical Ltd. filed a Form 6-K to furnish a press release. The release is titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update” and is attached as Exhibit 99.1, making it part of the public disclosure record.
What is the date of Alpha Tau Medical Ltd.’s Q3 2025 press release in this filing?
The press release attached to the Form 6-K is dated November 20, 2025. This same date appears on the Form 6-K signature page, indicating when the company formally submitted the report through its Chief Executive Officer, Uzi Sofer.
How is this Alpha Tau Medical Ltd. (DRTS) Form 6-K used in relation to other registrations?
The Form 6-K and its exhibits are incorporated by reference into Alpha Tau’s Form F-3 and Form S-8 registration statements. This means the information in the press release becomes legally part of those registration statements for disclosure purposes.
Which registration statements are updated by this Alpha Tau Medical Ltd. Form 6-K?
The filing incorporates the press release into Alpha Tau’s Form F-3 registrations with file numbers 333-271073, 333-264306, 333-274457 and 333-288240, and Form S-8 registrations with file numbers 333-264169, 333-270406, 333-277733 and 333-285745.
Who signed the November 2025 Form 6-K for Alpha Tau Medical Ltd. (DRTS)?
The Form 6-K was signed on behalf of Alpha Tau Medical Ltd. by Uzi Sofer. He signed in his capacity as Chief Executive Officer on November 20, 2025, satisfying the signature requirements under the Securities Exchange Act of 1934.
What exhibit is included with Alpha Tau Medical Ltd.’s November 2025 Form 6-K?
The Form 6-K includes one exhibit, labeled 99.1, which is the press release dated November 20, 2025. That press release contains Alpha Tau’s third quarter 2025 financial results and a corporate update, though its detailed contents are in the exhibit itself.